What are the side effects of FOLFIRI for Colorectal Cancer

Side Effects of FOLFIRI for Colorectal Cancer

FOLFIRI is a combination chemotherapy regimen commonly used to treat colorectal cancer. It combines three drugs: 5-FU (fluorouracil), leucovorin, and irinotecan. While it can be effective, it does come with significant side effects that you should understand.

Common Side Effects

According to the NCCN Guidelines for Colon Cancer, the main side effects associated with FOLFIRI include:

Gastrointestinal (Digestive) Effects

• Diarrhea - This is one of the most notable side effects, occurring in both early and late forms
• Nausea and vomiting
• Dehydration - Often related to diarrhea
• Mouth sores (stomatitis)
• Loss of appetite
• Abdominal cramping

Blood Cell Effects

• Severe neutropenia - A significant drop in white blood cells (infection-fighting cells), which increases infection risk
• Low red blood cell counts (anemia) - Can cause fatigue and shortness of breath
• Low platelet counts (thrombocytopenia) - Can affect bleeding and bruising

Other Side Effects

• Fatigue and weakness (asthenia)
• Hair loss (alopecia)
• Hand-foot syndrome - Tenderness, dryness, and peeling of palms and soles
• Neuropathy - Numbness and tingling in hands and feet (can be cumulative over time)
• Changes in taste
• Nail changes

Important Consideration: UGT1A1 Genetic Testing

According to NCCN Guidelines, irinotecan (one component of FOLFIRI) is inactivated by an enzyme called UGT1A1. Some people have genetic variations that affect how their body processes this drug.

Key points:

• Patients with Gilbert syndrome or elevated bilirubin levels should use irinotecan with caution and at reduced doses
• A commercial test exists to detect the UGT1A1*28 allele, which is associated with reduced enzyme activity
• If you experience irinotecan toxicity, dose reduction is needed regardless of genetic test results

Questions to ask your doctor:

1. Should I have UGT1A1 genetic testing before starting FOLFIRI?
2. Do I have Gilbert syndrome or elevated bilirubin that would affect my dosing?
3. What is my baseline risk for severe side effects?

Managing Side Effects

The good news: side effects can often be managed or reduced. According to treatment guidelines:

• Anti-nausea medications can be prescribed preventatively (before your next cycle if you had nausea previously)
• Dose adjustments are possible - your doctor may reduce doses or discontinue certain drugs if toxicity becomes severe
• Treatment schedules can be modified to fit your tolerance and lifestyle
• Oxaliplatin discontinuation is often considered after 3-4 months of therapy to reduce cumulative nerve damage, while continuing other agents

Age Considerations

Research from the NCCN Guidelines shows that patients under age 50 receiving FOLFIRI-based therapy had:

• Lower risks of severe neutropenia, diarrhea, and weakness
• BUT higher rates of nausea and vomiting

This means side effect patterns may vary based on your age and overall health.

When to Contact Your Doctor

Seek immediate medical attention for:

• Fever or signs of infection (from low white blood cells)
• Severe diarrhea lasting more than a few hours
• Severe vomiting or inability to keep food/fluids down
• Unusual bleeding or bruising
• Severe abdominal pain
• Difficulty breathing or chest pain

Key Takeaway

While FOLFIRI side effects can be significant, they are manageable and often temporary. The severity varies greatly between patients. Keeping a daily log of side effects (as recommended by oncologists) helps your doctor adjust your treatment proactively rather than reactively.

Important questions for your oncology team:

1. Which side effects should I expect based on my specific health situation?
2. What preventive medications will you prescribe?
3. How will we monitor for serious side effects like infection or severe diarrhea?
4. What's your plan if I develop intolerable side effects?
5. Are there any clinical trials combining FOLFIRI with supportive care strategies?

---

Sources:

• NCCN Guidelines for Colon Cancer (Version 5.2025) - Comprehensive recommendations on FOLFIRI toxicity management and irinotecan dosing considerations
• Let's Win Pancreatic Cancer - Patient-focused information on chemotherapy side effect management strategies

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.